A proprietary blend is rarely formulated to protect intellectual property from competitors who possess analytical testing tools. In practice, the undisclosed matrix serves to mask negligible doses of expensive active ingredients behind cheap carrier compounds. When reviewing physical vitality supplements, our ledger immediately docks points from any product withholding exact milligram counts per compound.
The Deceptive Anatomy of a Complex
Labels that aggregate five to ten botanical extracts under a single generic headline make clinical assessment impossible. An audit of common circulation products often reveals a prominent headline extract representing less than five percent of the total collective weight. The rest is frequently composed of inexpensive fillers or negligible micro-doses that provide label decoration without physiological efficacy.
Benchmarking Against Peer-Reviewed Protocols
Every legitimate human trial relies on a standardized, unvarying dosage curve to demonstrate efficacy. When a commercial formula conceals whether it delivers 50 milligrams or 500 milligrams of an adaptogen, it disconnects itself from the scientific literature. Consumers are left paying full price for sub-therapeutic mixtures that cannot replicate published clinical outcomes.
Our Standards for Transparent Evaluation
We require uncompromised label transparency as a baseline requirement for any favorable rating. Formulas that publish individual active compound quantities, standardized extract percentages, and third-party validation certificates receive prioritized placement in our searchable evaluation registry.